FCCC LOGO Faculty Publications
Robertson FM , Bondy M , Yang W , Yamauchi H , Wiggins S , Kamrudin S , Krishnamurthy S , Le-Petross H , Bidaut L , Player AN , Barsky SH , Woodward WA , Buchholz T , Lucci A , Ueno N , Cristofanilli M
Inflammatory Breast Cancer The Disease, the Biology, the Treatment
Ca-a Cancer Journal for Clinicians. 2010 Nov-Dec;60(6) :351-375
PMID: ISI:000284242900004   
Back to previous list
Inflammatory breast cancer (IBC) is a rare and aggressive form of invasive breast cancer accounting for 2.5% of all breast cancer cases. It is characterized by rapid progression, local and distant metastases, younger age of onset, and lower overall survival compared with other breast cancers. Historically, IBC is a lethal disease with less than a 5% survival rate beyond 5 years when treated with surgery or radiation therapy. Because of its rarity, IBC is often misdiagnosed as mastitis or generalized dermatitis. This review examines IBC's unique clinical presentation, pathology, epidemiology, imaging, and biology and details current multidisciplinary management of the disease, which comprises systemic therapy, surgery, and radiation therapy. CA Cancer J Clin 2010;60:351-375. (C) 2010 American Cancer Society, Inc.
Robertson, Fredika M. Bondy, Melissa Yang, Wei Yamauchi, Hideko Wiggins, Shannon Kamrudin, Samira Krishnamurthy, Savitri Le-Petross, Huong Bidaut, Luc Player, Audrey N. Barsky, Sanford H. Woodward, Wendy A. Buchholz, Thomas Lucci, Anthony Ueno, Naoto Cristofanilli, Massimo Morgan Welch Inflammatory Breast Cancer Research Program and Clinic ; State of Texas ; American Airlines Susan G. Komen for the Cure Promise [KGO81287] The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The State of Texas Grant for Rare and Aggressive Cancers, and American Airlines Susan G. Komen for the Cure Promise Grant KGO81287 provided support for this study. 165 Wiley-blackwell publishing, inc; commerce place, 350 main st, malden 02148, ma usa 680ny